Could a popular weight loss shot also help tame Crohn's disease?
NCT ID NCT06774079
Summary
This small pilot study is testing whether adding a weight loss medication called tirzepatide (Zepbound) and a specific diet to standard Crohn's treatment can improve disease control. It will enroll 24 adults with mild Crohn's disease who are overweight and already on stable biologic medication. The main goal is to see if this combined approach is practical and helps patients stick to their treatment plan.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Miami
RECRUITINGMiami, Florida, 33136, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.